Clinical trial
A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to…
NCT00156884 · Alberta Health services, Other · Completed
Key facts
| NCT number | NCT00156884 |
|---|---|
| Title | A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer |
| Official title | A Randomized Phase II Trial of Strontium-89 With or Without Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer |
| Lead sponsor | Alberta Health services, Other |
| Collaborators | The Prostate Cancer Research Foundation of Canada Amersham Health Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hormone Refractory Prostate Cancer, Bone Metastases |
| Intervention type | Drug |
| Interventions | strontium-89, cisplatin |
| Enrollment | 58 |
| Start date | Aug 1, 2003 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 19, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: